ORD 7289/2025

—·EP3646825: A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Verfahrensführungsanordnungen
Parteien: Kläger
Meril Life Sciences Pvt Ltd.
Vertreter: Andreas von Falck (Hogan Lovells International LLP); Alexander Klicznik (Hogan Lovells International LLP); Felipe Zilly (Hogan Lovells International LLP); Roman Würtenberger (Hogan Lovells International LLP); Lukas Wollenschlaeger (Hogan Lovells International LLP); Beatrice Wilden (Hogan Lovells International LLP)
Beklagte
SWAT Medical AB
Respondent 1 (individual)
Division: Court of Appeal
Richter: Rian Kalden · Presiding judge, legally qualified judge
Ingeborg Simonsson · Legally qualified judge, judge-rapporteur
Patricia Rombach · Legally qualified judge
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 12. Feb. 2025

Entscheidungen

2025-02-12
Generic Order
Court of Appeal order in Meril Life Sciences Pvt. Ltd. v. SWAT Medical AB / Respondent 1 concerning representation (R. 8.1 RoP). The appeal arose from a public access application (R. 262.1(b) RoP). The court held: (1) even lawyers and European Patent Attorneys who are themselves parties must be represented before the UPC; (2) representation is a public policy admissibility issue the court may raise at any time of its own motion; (3) Meril Life Sciences' late argument that the access request was inadmissible from the outset due to invalid representation was brought too late under R. 226 and R. 222.2 RoP.
Rechtsfragen:Mandatory representation before UPC (R. 8.1 RoP)Lawyers and EPAs as parties must still be representedAdmissibility of public access request under R. 262.1(b) RoPLate submission rule (R. 222.2 RoP)

Dokumente